Stifel analyst Brian Brophy lowered the firm’s price target on Everus Construction (ECG) to $67 from $85 and keeps a Buy rating on the shares. Q4 results were above expectations, initial 2025 revenue guidance was ahead of forecasts, and initial 2025 EBITDA bracketed consensus, the analyst tells investors. However, the firm believes the negative share price reaction reflects high expectations regarding 2025 guidance, slowing new award activity in Q4 and an unexpected 30-40 basis point year-over-year decline in implied 2025 EBITDA margin guidance excluding dis-synergies, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECG:
- Everus Construction Reports Strong 2024 Results
- Everus Construction reports Q4 EPS 67c, consensus 69c
- Everus Construction sees FY25 revenue $3.0B-$3.1B, consensus $2.95B
- ECG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Everus Construction price target raised to $80 from $70 at Oppenheimer
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue